Neurorehabilitation Devices Market (Product: Neurorobotic Systems, Wearable Devices, Brain-computer Interface, and Brain Stimulators [Non-invasive Stimulators and Invasive Stimulators]; and Application: Stroke, Parkinson’s Disease, Multiple Sclerosis, Cerebral Palsy, Brain & Spinal Cord Injury, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2030

Description

Gamification in Rehabilitation through VR Promises Early Treatment in Stroke Patients

With growing prominence of the startup culture, neuroscientists are exploring opportunities in virtual reality (VR) to speed up recovery in stroke patients. For instance, MindMaze - a startup neurotechnology company won several accolades for gamification in rehabilitation catering to stroke survivors with the help of VR and neuroscience. This is evident since stroke application segment accounted for 47% of the neurorehabilitation devices market in 2018. Thus, companies in the neurorehabilitation devices market should collaborate with neuroscientists to deliver inspiring results in stroke rehabilitation.

Healthcare companies are harnessing the advantages of VR, since there is only a short window when the brain can bounce back in early stages of treatment. Hence, VR and neuroscience have helped to maximize the potential for full recovery. Companies are increasing efforts to increase the availability of VR devices in hospitals.

New Multi-electrode Stimulation Proves Efficacious in Treatment of Spinal Cord Injuries

New technologies in electrostimulation are engulfing the neurorehabilitation devices market. Researchers are increasing R&D to develop a new multi-electrode to stimulate the spinal cord in different points to improve patient quality of life. For instance, the international team of Sissa (International School for Advanced Studies), Italy, collaborated with the researchers at the University of California, Los Angeles and the University of Leeds to develop a new multi-electrode for spinal cord stimulation. Thus, companies in the market for neurorehabilitation devices should collaborate with researchers to advance in spinal cord stimulation.

The new electrode is capable of deploying diversified electric message to different fibers of the cord in a targeted and independent manner. This innovation has aided in fast recovery of voluntary limb movements. Hence, companies in the neurorehabilitation devices market are increasing their research efforts in the field of electrical stimulation to enhance recovery of motor functions.

Get a glimpse of the in-depth analysis through our Report Brochure

The novel approach of electric stimulation of the spinal cord has been receiving attention in recent years. This is evident since the brain & spinal cord injury application segment is predicted for exponential growth in the market for neurorehabilitation devices. The global neurorehabilitation devices market is estimated to reach a revenue of US$ 3.2 Bn by the end of 2027.

Companies Combine Robotic Neurorehabilitation Devices with Non-invasive Brain Machine Interfaces

Robotic neurorehabilitation is acquiring prominence in the neurorehabilitation devices market. With the introduction of novel technologies, companies are able to enhance capabilities of robots to offer cost-effective solutions in clinical practice. However, lack of effective training modalities in these robotic devices poses as a restraint for healthcare companies in the neurorehabilitation devices market. Hence, companies are increasing their efficacy to design robotic devices with predefined training modalities depending on the appropriate control strategies.

Companies in the neurorehabilitation devices market are developing robots with passive and active training modalities where the robot is capable of imposing and modulating trajectories with respect to the patient’s intention to move. Companies in the neurorehabilitation devices market combining robot-aided neurorehabilitation with non-invasive brain machine interfaces. Robot-aided neurorehabilitation in combination with proper training regimen is also found to improve patient recovery. Companies are increasing the production of assistive controllers to aid movement in impaired limbs. Various strategies such as assist-as-needed are being widely employed to reduce patient reliance on robots to accomplish the rehabilitative task.

VR and FES Hold Promising Future in Wearable Devices

Since wearable technology is gaining prominence in every day-life applications, companies in the neurorehabilitation devices market are innovating in wristbands that have the potential to rehabilitate patients who have suffered from stroke. As such, wearable devices product segment of the neurorehabilitation devices market is projected for aggressive growth and the global neurorehabilitation devices market is projected to expand at a staggering CAGR of 12.5% during the forecast period.

Likewise, Facebook agreed to acquire brain-computing startup CTRL-labs that specializes in the neural interface technology and develops wristbands that delivers machine-interpretable commands. With the help of these novel wristbands, companies in the market for neurorehabilitation devices are tapping opportunities to improve recovery in patients suffering from multiple sclerosis, Parkinson’s disease, and other neurodegenerative diseases. Companies in the market for neurorehabilitation devices are also experimenting with VR systems and functional electrical stimulation (FES) to innovate in wearable technology.

Analysts’ Viewpoint

Gamifying rehabilitation for stroke survivors with the help of VR has set the benchmark for innovation in the neurorehabilitation devices market. Neurorobotic systems and non-invasive brain stimulation have helped to enhance the quality and intensity of neurorehabilitation. Non-invasive brain stimulation is being combined with advanced technologies, such as functional MRI and near infrared spectroscopy, to treat neurological disorders.

Electric stimulation is acquiring popularity to restore lost functionality due to spinal cord injuries. However, physiological stimulus is lost after injury, which poses as a hurdle for healthcare companies. Hence, companies should innovate in the new multi-electrode stimulation technology to make the injured spinal cord more responsive to weak incoming messages coming from the brain.

Neurorehabilitation Devices Market: Overview

The neurorehabilitation devices market for the historical period 2017–2018 and forecast period 2019–2027, rise in prevalence of neurological disorders, aging population, technological advancements, entry of new players, and increase in access to healthcare are anticipated to drive the global neurorehabilitation devices market

According to the report, the global neurorehabilitation devices market was valued at US$ 1.12 Bn in 2018 and is projected to expand at a CAGR of 12.5% from 2019 to 2027

Rise in Prevalence of Neurological Disorders and Surge in Awareness about Usage and Benefits of Robotic Neurorehabilitation: A Key Driver

Rise in prevalence of neurological diseases has increased the patient pool undergoing interventional procedures followed by rehabilitation therapies globally, resulting in high demand for neurorehabilitation devices. Stroke is the leading cause of long-term disability in the U.S. Rise in prevalence of stroke across the world has increased the need of rehabilitation robotics technologies. According to the Internet Stroke Center, around 795,000 people suffer from stroke in the U.S. every year. Moreover, rise in prevalence of neuromotor disorders such as cerebral palsy, brain injury, and spinal cord injury globally drives demand for neurorobotic technologies, thereby fueling the growth of the neurorehabilitation devices market.

Manufacturers are making efforts to increase awareness among healthcare professionals and patients about the usage and benefits of neurorehabilitation robots. Neurorehabilitation robot manufacturers in developed countries such as the U.S. have begun to reach local communities by offering Continual Medical Education (CME) classes. This leads to increase in awareness among physicians and surgeons about the availability and usage of neurorehabilitation robots, thereby fueling the growth of the neurorehabilitation devices market.

Focus on Geographic Expansion

Companies in the global neurorehabilitation devices market are increasingly turning to in-licensing and collaboration agreements to launch new products in North America and Europe. Rise in demand for technology-driven solutions, economic growth, and increase in awareness about neurological disorders present significant opportunities for players operating in the global neurorehabilitation devices market.

According to industry experts, high cost of neurorehabilitation devices could hamper the market growth. This is particularly true for various underdeveloped and developing countries. Prevalence of neurological disorders is high in developing regions such as Asia, Africa, Latin America, and the Middle East. Hence, growth of neurorehabilitation devices is expected to be faster in these regions. However, high cost of neurorobotic systems and wearable devices would be a deterrent for exploiting the full potential of these regions.

Long Implantation Procedure, High Cost, and Lack of Skilled Professionals to Hamper Market

The global neurorehabilitation devices market is technology driven. Introduction of new technologies in the market increases the demand for these systems due to improved efficiency and outcomes. However, high cost of these new devices raises the affordability issue, which hampers the growth of the neurorehabilitation devices market, especially in the developing countries. Moreover, lack of reimbursement affects demand for neurorehabilitation devices.

Neurorehabilitation devices have been adopted by patients, therapists, and doctors in the last decade. However, standardization in training for product and accreditation guidelines to ensure physician competence and patience safety is still lacking. Hence, failure of neurorehabilitation devices has been observed during clinical practice, which results from product failure.

Neurorehabilitation Devices Market: Competition Landscape

This report profiles major players in the global neurorehabilitation devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

The neurorehabilitation devices market is less fragmented with the presence of a few international as well as regional players

Leading players operating in the global neurorehabilitation devices market are

  • Bionik Laboratories Corp.
  • Ekso Bionics
  • ReWalk Robotics
  • Tyromotion GmbH
  • Boston Scientific Corporation
  • Medtronic plc

Key Questions Answered in Neurorehabilitation Devices Market Report

  • What is the scope of growth of product companies in the neurorehabilitation devices market?
  • What will be the Y-o-Y growth of the neurorehabilitation devices market between 2019 and 2027?
  • What is the influence of changing trends in technologies on the neurorehabilitation devices market?
  • Will North America continue to remain the most profitable regional market for neurorehabilitation devices providers?
  • Which factors are anticipated to impede the growth of the neurorehabilitation devices market during the forecast period?
  • Which are the leading companies in the neurorehabilitation devices market?

Neurorehabilitation Devices Market – Segmentation

Product

  • Neurorobotic Systems
  • Wearable Devices
  • Brain-computer Interface
  • Brain Stimulators
  • Non-invasive Stimulators
  • Invasive Stimulators

Application

  • Stroke
  • Parkinson’s Disease
  • Multiple Sclerosis
  • Cerebral Palsy
  • Brain & Spinal Cord Injury
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENT

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Neurorehabilitation Devices Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Neurorehabilitation Devices Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Porter’s Five Force Analysis

5. Key Insights

    5.1. Regulatory Scenario, by Region/Globally

    5.2. Funding

    5.3. Robotics Mergers & Acquisitions 

    5.4. Pricing Assessment

    5.5. Technological Advancements

    5.6. Recent Developments (Product approval, Installation, Launch, Partnership/Agreement)

6. Global Neurorehabilitation Devices Market Analysis and Forecast, by Application

    6.1. Introduction & Definition

        6.1.1. Key Findings / Developments

    6.2. Global Neurorehabilitation Devices Market Value Forecast, by Application, 2017–2027

        6.2.1. Stroke 

        6.2.2. Parkinson’s Disease

        6.2.3. Multiple Sclerosis 

        6.2.4. Cerebral Palsy

        6.2.5. Brain and Spinal Cord Injury

        6.2.6. Others

    6.3. Global Neurorehabilitation Devices Market Attractiveness, by Application

7. Global Neurorehabilitation Devices Market Analysis and Forecast, by Product

    7.1. Introduction & Definition

        7.1.1. Key Findings / Developments

    7.2. Global Neurorehabilitation Devices Market Value Forecast, by Product, 2017–2027

        7.2.1. Neurorobotic Systems 

        7.2.2. Wearable Devices 

        7.2.3. Brain-computer Interface

        7.2.4. Brain Stimulators

            7.2.4.1. Non-invasive Stimulators

            7.2.4.2. Invasive Stimulators

    7.3. Global Neurorehabilitation Devices Market Attractiveness, by Product 

8. Global Neurorehabilitation Devices Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Global Neurorehabilitation Devices Market Value Forecast, by Region

        8.2.1. North America 

        8.2.2. Europe 

        8.2.3. Asia Pacific 

        8.2.4. Latin America 

        8.2.5. Middle East & Africa 

    8.3. North America Neurorehabilitation Devices Market Attractiveness, by Region

9. North America Neurorehabilitation Devices Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. North America Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

        9.2.1. Stroke 

        9.2.2. Parkinson’s Disease

        9.2.3. Multiple Sclerosis 

        9.2.4. Cerebral Palsy

        9.2.5. Brain and Spinal Cord Injury

        9.2.6. Others

    9.3. North America Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

        9.3.1. Neurorobotic Systems 

        9.3.2. Wearable Devices 

        9.3.3. Brain-computer Interface

        9.3.4. Brain Stimulators

            9.3.4.1. Non-invasive Stimulators

            9.3.4.2. Invasive Stimulators

    9.4. North America Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country, 2017–2027

        9.4.1. U.S.

        9.4.2. Canada

    9.5. North America Neurorehabilitation Devices Market Attractiveness Analysis 

        9.5.1. By Application

        9.5.2. By Product 

        9.5.3. By Country

10. Europe Neurorehabilitation Devices Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Europe Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

        10.2.1. Stroke 

        10.2.2. Parkinson’s Disease

        10.2.3. Multiple Sclerosis 

        10.2.4. Cerebral Palsy

        10.2.5. Brain and Spinal Cord Injury

        10.2.6. Others

    10.3. Europe Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

        10.3.1. Neurorobotic Systems 

        10.3.2. Wearable Devices 

        10.3.3. Brain-computer Interface

        10.3.4. Brain Stimulators

            10.3.4.1. Non-invasive Stimulators

            10.3.4.2. Invasive Stimulators

    10.4. Europe Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe 

    10.5. Europe Neurorehabilitation Devices Market Attractiveness Analysis 

        10.5.1. By Application

        10.5.2. By Product 

        10.5.3. By Country/Sub-region

11. Asia Pacific Neurorehabilitation Devices Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Asia Pacific Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

        11.2.1. Stroke 

        11.2.2. Parkinson’s Disease

        11.2.3. Multiple Sclerosis 

        11.2.4. Cerebral Palsy

        11.2.5. Brain and Spinal Cord Injury

        11.2.6. Others

    11.3. Asia Pacific Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

        11.3.1. Neurorobotic Systems 

        11.3.2. Wearable Devices 

        11.3.3. Brain-computer Interface

        11.3.4. Brain Stimulators

            11.3.4.1. Non-invasive Stimulators

            11.3.4.2. Invasive Stimulators 

    11.4. Asia Pacific Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific 

    11.5. Asia Pacific Neurorehabilitation Devices Market Attractiveness Analysis 

        11.5.1. By Application

        11.5.2. By Product 

        11.5.3. By Country/Sub-region

12. Latin America Neurorehabilitation Devices Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Latin America Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

        12.2.1. Stroke 

        12.2.2. Parkinson’s Disease

        12.2.3. Multiple Sclerosis 

        12.2.4. Cerebral Palsy

        12.2.5. Brain and Spinal Cord Injury

        12.2.6. Others

    12.3. Latin America Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

        12.3.1. Neurorobotic Systems 

        12.3.2. Wearable Devices 

        12.3.3. Brain-computer Interface

        12.3.4. Brain Stimulators

            12.3.4.1. Non-invasive Stimulators

            12.3.4.2. Invasive Stimulators

    12.4. Latin America Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America Latin America 

    12.5. Latin America Neurorehabilitation Devices Market Attractiveness Analysis 

        12.5.1. By Application

        12.5.2. By Product 

        12.5.3. By Country/Sub-region

13. Middle East & Africa Neurorehabilitation Devices Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Middle East & Africa Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

        13.2.1. Stroke 

        13.2.2. Parkinson’s Disease

        13.2.3. Multiple Sclerosis 

        13.2.4. Cerebral Palsy

        13.2.5. Brain and Spinal Cord Injury

        13.2.6. Others

    13.3. Middle East & Africa Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

        13.3.1. Neurorobotic Systems

        13.3.2. Wearable Devices

        13.3.3. Brain-computer Interface

        13.3.4. Brain Stimulators

            13.3.4.1. Non-invasive Stimulators

            13.3.4.2. Invasive Stimulators

    13.4. Middle East & Africa Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa 

    13.5. Middle East & Africa Neurorehabilitation Devices Market Attractiveness Analysis 

        13.5.1. By Application

        13.5.2. By Product 

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (by Tier and Size of companies)

    14.2. Market Share / Position Analysis by Company (2016)

    14.3. Competitive Business Strategies

    14.4. Company Profiles

        14.4.1. Bionik Laboratories Corp.

            14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.1.2. Growth Strategies

            14.4.1.3. SWOT Analysis

        14.4.2. Ekso Bionics

            14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.2.2. Growth Strategies

            14.4.2.3. SWOT Analysis

        14.4.3. Kinestica

            14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.3.2. Growth Strategies

            14.4.3.3. SWOT Analysis

        14.4.4. Neurostyle Pte Ltd

            14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.4.2. Growth Strategies

            14.4.4.3. SWOT Analysis

        14.4.5. Saebo, Inc.

            14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.5.2. Growth Strategies

            14.4.5.3. SWOT Analysis

        14.4.6. Reha Technology AG 

            14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.6.2. Growth Strategies

            14.4.6.3. SWOT Analysis 

        14.4.7. MindMaze Holding SA

            14.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.7.2. Growth Strategies

            14.4.7.3. SWOT Analysis

        14.4.8. Neuro Device Group S.A.

            14.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.8.2. Growth Strategies

            14.4.8.3. SWOT Analysis

        14.4.9. DIH Technologies Corporation (Hocoma)

            14.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.9.2. Growth Strategies

            14.4.9.3. SWOT Analysis

        14.4.10. ReWalk Robotics

            14.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.10.2. Growth Strategies

            14.4.10.3. SWOT Analysis

        14.4.11. Tyromotion GmbH

            14.4.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.11.2. Growth Strategies

            14.4.11.3. SWOT Analysis

        14.4.12. Boston Scientific Corporation

            14.4.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.12.2. Growth Strategies

            14.4.12.3. SWOT Analysis

        14.4.13. Medtronic plc

            14.4.13.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.13.2. Growth Strategies

            14.4.13.3. SWOT Analysis

Choose License Type

Checkout Inquiry Sample